The female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 in Myanmar is currently 20.2%, a decrease of 0.4% (-1.9%) compared to 2018.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Myanmar
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Myanmar
Female CVD, cancer, diabetes or CRD
More indicators for Myanmar
Out-of-pocket expenditure PPP per capita
intl dollar178
-intl dollar17
(2021)
Newborns protected against tetanus
88%
0%
(2022)
Female wasting in children
6.2%
-0.9%
(2016)
Birth registration
81.3%
+8.9%
(2016)
Female prevalence of HIV
0.4%
0%
(2022)
Contraceptive modern method prevalence
51.3%
+12.9%
(2016)
Myanmar Female CVD, cancer, diabetes or CRD between 2000 and 2019
| Period | Female CVD, cancer, diabetes or CRD | Change |
|---|---|---|
| 2019 | 20.2% | -0.4% |
| 2018 | 20.6% | -0.3% |
| 2017 | 20.9% | -0.6% |
| 2016 | 21.5% | -0.3% |
| 2015 | 21.8% | -0.4% |
| 2014 | 22.2% | -0.3% |
| 2013 | 22.5% | -0.5% |
| 2012 | 23% | -0.8% |
| 2011 | 23.8% | -0.8% |
| 2010 | 24.6% | -0.9% |
| 2009 | 25.5% | -0.9% |
| 2008 | 26.4% | -1% |
| 2007 | 27.4% | -0.8% |
| 2006 | 28.2% | -0.4% |
| 2005 | 28.6% | -0.6% |
| 2004 | 29.2% | -0.2% |
| 2003 | 29.4% | -0.1% |
| 2002 | 29.5% | -0.2% |
| 2001 | 29.7% | -0.4% |
| 2000 | 30.1% |